IDC MarketScape: Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment
See Why Medidata Was Recognized as a Leader
See why we believe Medidata is the only vendor whose evidence starts in the clinical trial, linking trial data to real-world data with regulatory expertise behind it.
Learn more about:
- Why Medidata was named a Leader among 12 vendors assessed.
- Why evidence that starts in the clinical trial matters as RWE moves from pilots to enterprise scale with AI and synthetic data.
- Medidata’s capabilities, including historical clinical trial data from 43,000 trials, Medidata Link, Study Feasibility, and Synthetic Control Arms.
SOURCE: “IDC MarketScape: Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment”, September 2026, IDC # US54122226
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of technology and suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier’s position within a given market. The Capabilities score measures supplier product, go-to-market and business execution in the short-term. The Strategy score measures alignment of supplier strategies with customer requirements in a 3-5-year timeframe. Supplier market share is represented by the size of the icons.